Our Recommendations
- Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19 (2021)
- Orientations sur l’élaboration d’un plan national de déploiement et de vaccination applicable aux vaccins contre la COVID-19 (2020)
- Immunization in the context of COVID-19 pandemic (2020)
- Institute for Health Metrics and Evaluation (2022)
- La vaccination dans le contexte de la pandémie de COVID-19 (2020)
New Publications
- Guidance on development and implementation of a national deployment and vaccination plan for vaccines against pandemic influenza and other respiratory viruses of pandemic potential (2023)
- The Big Catch-Up: An Essential Immunization Recovery Plan for 2023 and Beyond (2023)
- Modelling COVID-19 vaccination status and adherence to public health and social measures, Eastern Mediterranean Region and Algeria (2023)
- Meeting of the Strategic Advisory Group of Experts on Immunization, October 2022: conclusions and recommendations (2023)
- COVAX: Structure and Principles (2022)
Filter
482
Featured
Recommendations
71
Language
Document type
Fact sheets
129
Videos
87
Guidelines
60
Resource Platforms
57
Studies & Reports
47
Manuals
36
Infographics
21
Strategic & Response Plan
13
Training Material
9
Online Courses
8
Situation Updates
7
No document type
6
Brochures
1
App
1
Countries / Regions
Germany
38
Middle East and North Africa
20
Latin America and the Carribbean
18
Brazil
13
Ukraine
11
Russia
11
Africa
10
Syria
9
Yemen
9
West and Central Africa
8
East and Southern Africa
8
South Africa
6
South Sudan
5
China
4
Mozambique
4
Global
4
Congo, Democratic Republic of
4
United Kingdom
4
Sudan
4
Angola
4
Colombia
3
Guinea-Bissau
3
Lebanon
3
India
3
Philippines
2
Eastern Europe and Central Asia
2
Western and Central Europe
2
Argentina
2
Mali
2
Thailand
1
Kenya
1
Ghana
1
Sierra Leone
1
Kazakhstan
1
Nigeria
1
Canada
1
Senegal
1
Niger
1
Burkina Faso
1
Malawi
1
Morocco
1
USA
1
Saudi Arabia
1
South–East Asia Region
1
Gabon
1
Jamaica
1
Tunisia
1
South Korea
1
Belarus
1
French Guyana
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Bangladesh
1
Vietnam
1
Uganda
1
Nicaragua
1
Ethiopia
1
Indonesia
1
Somalia
1
Ecuador
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
COVID-19
118
Information, Education and Communication (IEC)
44
Immunization
17
Guidelines
16
Vaccine-preventable Diseases
9
Policies
9
x MEDBOX Issue Brief & Annual Reports x
7
Capacity Building
5
Statistics
5
Studies & Reports
4
Pharmacy & Technology
3
Online Courses & Platforms
3
IEC Material
2
Medical Devices & Equipment
2
Women & Child Health
2
Capacity Building
1
Community Health
1
Drugs & Medical Equipment
1
Community Health
1
Waste Management
1
Toolboxes
Communication Material
131
Videos
89
Vaccine Hesitancy & Myths
83
Access & Strategy
74
Immunization Guidelines
60
Fair Allocation & Ethical Aspects
55
Dashboards & Resource Platforms
43
Logistics & Supply
36
COVAX Initiative
18
Booster Doses
13
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
The introduction of vaccines for coronavirus disease 2019 (COVID-19) added another measure to the existing set of
recommended preventive measures (wearing a mask in public, keeping a distance from other people and regular handwashing). The roll-out of the vaccines, however, raised concerns that vac...
The backsliding of immunization coverage during the COVID-19 pandemic, combined with delayed catch-up efforts has resulted in a large and growing immunity gap. There is an urgent need to close this gap, and enable millions of missed children to be vaccinated. The Essential Immunization Recovery Plan...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
Coronavirus (COVID-19) Vaccinations
recommended
In our Data Explorer you can see our COVID-19 vaccination data — you can also visualize the latest data on confirmed cases, deaths, and testing.
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
Version 2.3 , 21 April 2022. The CVIC tool supports credible COVID-19 vaccination costing to facilitate a dialogue with stakeholders, while maintaining sensitivity to protect essential health services.
The CVIC tool provides a structured and comprehensive estimation of incremental operational and...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
